JPRN-UMIN000001584CompletedPhase 2
A Phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for Stage III gastric cancer - A Phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for Stage III gastric cancer (KUGC03)
Department of Surgery Graduate School of Medicine, Kyoto University0 sites49 target enrollmentStarted: December 17, 2008Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 49
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1)Active bleeding from the tumor 2)Paralysis of intestine or ileus 3)Diarrhea(watery stool) 4)Patient who requires continuous use of flucytosine, phenytoin or warfarin potassium 5)Synchronous multicancer 6)Serous infection 7)Interstitial pneumonitis or fibroid lung 8)Pleural effusion or ascites requiring control 9)Uncontrollable diabetes mellitus, uncontrollable hypertention, heart insufficiency, myocardial infarction within 6 months,uncontrolled arrhythmia or angina 10)Patient who is pregnant or in lactation, or wish to become pregnant during this study.Male patient who intends to make someone pregnant during this study 11)Patient who has experienced serious drug allergy in the past 12)Patient with severe phyciatric disease 13)Patient who is judged to be inappropriate as subject to this study by the principal investigator or the doctors in charge
Investigators
Similar Trials
Completed
Phase 2
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 in advanced esophageal cancer patients with normal oral intakeesophageal cancerJPRN-UMIN000017153Second Department of Surgery, Wakayama Medical University40
Completed
Phase 2
A phase II study of neoadjuvant chemotherapy with nab-paclitaxel followed by FEC in patitents with operable breast cancerbreast cancerJPRN-UMIN000030692kyushu Breast Cancer Study Group40
Recruiting
Phase 2
A phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin followed by surgery in cStageIII advanced gastric cancer patientsGastric cancerJPRN-UMIN000023405Wakayama Medical University, Second Department of Surgery48
Recruiting
Phase 1
Phase I, II study of neoadjuvant chemotherapy with gemcitabine and nab-paclitaxel for resectable pancreatic cancerpancreatic ductal cancerJPRN-jRCTs021200003Ishido Keinosuke30
Completed
Not Applicable
PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancerHER2 positive resectable primary breast cancerJPRN-UMIN000008465Osaka Breast Cancer Chemo-Endocrine Therapy Study Group30